arrow_back Back to App

Accelerating Medical Innovation: New Center for Drug and Vaccine Development

This Act establishes a Center for Biomedical Innovation and Development, a consortium of universities overseen by BARDA, to significantly speed up the research, development, and manufacturing of advanced medical countermeasures. This initiative aims to provide citizens with faster access to innovative treatments, drugs, vaccines, and devices, enhancing national preparedness for future health crises.
Key points
Creation of a Center to help researchers and private companies move laboratory discoveries into advanced development, including assistance with clinical trials and pilot manufacturing.
Focus on novel technologies and products designed to fulfill unmet medical needs or substantially improve the manufacturing processes for existing drugs and devices.
Mandate for international coordination to strengthen global health security and expand worldwide strategies for countermeasure research and development.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_1441
Sponsor: Sen. Cornyn, John [R-TX]
Process start date: 2023-05-04
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Accelerating Biomedical Innovation Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_1441.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-05-04.

What are the main provisions?

Key points include:

  • Creation of a Center to help researchers and private companies move laboratory discoveries into advanced development, including assistance with clinical trials and pilot manufacturing.
  • Focus on novel technologies and products designed to fulfill unmet medical needs or substantially improve the manufacturing processes for existing drugs and devices.
  • Mandate for international coordination to strengthen global health security and expand worldwide strategies for countermeasure research and development.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Cornyn, John [R-TX].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health Education